Vivimed Labs Ltd

VIVIMEDLAB
NSE· Healthcare
7.75
+0.36 (+4.87%)
52W Low · ₹5.1552W High · ₹20.59
Near 52W Low
Market Cap
₹52.98L Cr
Volume
98.7K
Prev Close
₹5.26
ISIN
INE526G01021

Orion Score

Fundamentals-based quality & risk · not a recommendation

5/100
Avoid

Vivimed Labs Ltd scores 5/100 (Avoid) on the Orion Score — poor business quality (4), poor growth (6) and poor balance-sheet safety (3). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
4
Growth
6
Safety
3
Value

Full Orion analysis

Risk checks

  • Very weak fundamentals (Piotroski F 1/9)
  • Micro-cap (~Rs 53 cr) — limited reliability/liquidity
  • Thinly traded (~Rs 11.3 L/day) — hard to act on

Forensic accounting

Piotroski F 1/9

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

65/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
No Data
D/E unavailable
QUALITY
Low Quality
ROCE -5.7% — poor capital efficiency
MOMENTUM
Neutral
RSI 25.8 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q3 FY2026

P/E Ratio
ROCE
-5.66%
ROE (1Y)
D/E Ratio
OPM
-97.25%
TTM EPS
₹-4.21
Dividend Yield
0.00%
Qtrly Sales
₹15.99 Cr
Qtrly Profit
₹-16.55 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q3 2026₹15.99₹-16.55-97.3%₹-2.00
Q2 2026₹20.61₹-7.3-28.4%₹-0.88
Q1 2026₹21.39₹-5.49-24.7%₹-0.66
Q4 2025₹25.61₹-5.6-14.4%
Q3 2025₹36.51₹-5.97-15.2%₹-0.72

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2025₹116.27₹-31.96₹-9.89-24.9%
FY 2024₹149.07₹-45.45₹-24.67-13.8%
FY 2023₹187.1₹-328.54₹-187.24-109.9%
FY 2022₹236.57₹-67.65₹-8.01-11.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
VIVIMEDLAB₹53 Cr-5.66%-97.25%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹88,148 Cr25.3912.55%9.93%0.21x15.11%
ASTERDM₹68,390 Cr104.348.93%10.07%0.46x13.98%
ABBOTINDIA₹59,509 Cr38.2836.31%34.46%0.04x27.01%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹920.83₹950.91₹995.05₹1,266.02
Equity₹-35.17₹-5.46₹39.42₹364.29
Total Debt₹376.33₹378.79₹381.03₹358.88
Cash₹0.71₹1.63₹3.76₹7.18
Net Debt₹375.62₹375.3₹374.8₹351.7
Working Capital₹-80.64₹-67.74₹-85.1₹133.87

Shareholding Pattern

Q1 FY2027

Promoter
16.75%
FII
5.96%
DII
4.88%
Public
72.41%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202716.75% ↑5.96% ↑4.88%72.41% ↓
Q3 FY20267.76%1.64%90.47%
Q2 FY20267.76%1.64%90.47%
Q1 FY20267.76% ↓1.64%90.47% ↑
Q4 FY202520.94%1.64%77.3%
Q3 FY202520.94%1.64%77.3%
Q2 FY202520.94%1.64%77.3%
Q1 FY202520.94%1.64%77.3%

Corporate Actions

No recent corporate actions

Analyse VIVIMEDLAB with Orion AI

Ask: "Is Vivimed Labs Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Vivimed Labs Ltd (VIVIMEDLAB) Stock

Vivimed Labs Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE526G01021. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.